Skip to Main Content

Paper Details

Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Nat Commun
69
2018
APOBEC, B2M, CDH1 mutations, Cancer, GATA3, HER2-, HR, HR+, HR+/HER2- tumors, KDM6A, PIK3CA, PIK3CA and, PLK2, RNA, TP53, breast cancer, breast cancers, homologous recombination deficiency, mutated genes, patients, tumors
Author NameAffiliation
Markus RiesterNovartis Institutes for BioMedical Research
Markus RiesterNovartis Institutes for BioMedical Research
Scott MahanNovartis Institutes for BioMedical Research
Rebecca J LearyNovartis Institutes for BioMedical Research
Dominic FitzgeraldInstitute for Genomics and Systems Biology, University of Chicago
A Jason GrundstadInstitute for Genomics and Systems Biology, University of Chicago
Chibuzor NkwodimmahUniversity of Ibadan
Michael MorrisseyNovartis Institutes for BioMedical Research
Jiebiao WangUniversity of Chicago
Wendy WincklerNovartis Institutes for BioMedical Research
Peter Van LooThe Francis Crick Institute
Peter Van LooUniversity of Leuven
Barbara L WeberNovartis Institutes for BioMedical Research
Barbara L WeberNovartis Institutes for BioMedical Research
Kevin P WhiteInstitute for Genomics and Systems Biology, University of Chicago
Kevin P WhiteTempus Labs Inc.
Jordi BarretinaNovartis Institutes for BioMedical Research
Jordi BarretinaGirona Biomedical Research Institute (IDIBGI)
  • 1 - 18

Datasets

Release 1.2